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CSF, cerebrospinal fluid 
CTB, cholera toxin-B 
EGF, epidermal growth factor 
EM, electron microscopy 
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ICD, intracellular domain 
MN, motor neuron 
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Pi-elF2α, phosphorylated-eukaryotic initiation factor 2 
PM, plasma membrane 
S1R, sigma-1 receptor 
SOD1, superoxide dismutase 1 
SSC, subsynaptic cistern 
TSA, tyramide signal amplification 
VAChT, vesicular acetylcholine transporter 
VGLUT1, vesicular glutamate transporter 1 
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Abstract 
C-type synaptic boutons are cholinergic motor neuron (MN) afferents displaying an 
endoplasmic reticulum-related subsynaptic cistern (SSC) adjacent to the postsynaptic 
membrane. A constellation of proteins is clustered at C-boutons, including M2 muscarinic 
receptors, potassium channels and sigma-1 receptors. We previously found that neuregulin 
(NRG) 1 is associated with C-boutons at postsynaptic SSCs, whereas its ErbB receptors are 
located at the presynaptic compartment. C-bouton-mediated regulation of MN excitability has 
been implicated in MN vulnerability. To address the involvement of C-boutons during 
pathological conditions, we investigated their plastic changes after electrical stimulation, 
pharmacological treatments and peripheral nerve axotomy. NRG1 clusters were disrupted in 
acutely stressed MNs and after tunicamycin-induced ER stress. In axotomized MNs C-bouton 
loss occurred in concomitance with microglial recruitment and was prevented by the ER-stress 
inhibitor salubrinal. Activated microglia displayed a positive chemotaxis to C-boutons. Analysis 
of transgenic mice overexpressing NRG1 type I and type III isoforms revealed that NRG1 type III 
acts as a specific organizer of SSC-like structures, whereas NRG1 type I promotes cholinergic 
synaptogenesis. Thus, distinct NRG1 isoform-mediated signaling functions regulate the 
complex matching between pre- and postsynaptic elements at C-boutons. Overall, these data 
provide new insights into C-bouton-associated molecules as therapeutic targets in MN disease. 
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Introduction 
Lower motor neurons (MNs) in the ventral spinal cord and brain stem project to skeletal 
muscles and govern the final efferent pathway that determines motor behavior. To achieve a 
coordinated control of muscle activity, MNs receive a variety of synaptic inputs, which shape 
appropriate patterns of discharge of muscle-specific MN pools (1, 2). Among the synaptic 
afferents involved in the regulation of MN excitability, C-boutons are particularly relevant due 
to their capacity to modulate the strength of the action potential afterhyperpolarization (AHP) 
via a reduction of outward K+ currents (3). C-boutons originate from cholinergic V0C 
interneurons located close to the central canal (4) and display a particular postsynaptic 
morphology with a prominent endoplasmic reticulum (ER)-related subsynaptic cistern (SSC) (3, 
5). In addition to M2 muscarinic acetylcholine receptors (AChRs) at the postsynaptic plasma 
membrane (PM) (6), a specific constellation of signaling proteins in the PM and SSC of C-
boutons has been described. These include: the voltage-gated K+ channel Kv2.1 (7), Ca2+ 
activated K+ (SK) channels (8), and sigma-1 receptors (S1Rs, (9). Most of these proteins are 
clustered in non-overlapping microdomains within SSC (10, 11), but their exact roles and 
functional organization are largely unknown. One novel intriguing aspect of the molecular 
assembly at C-boutons is the accumulation of neuregulin (NRG) 1 in the SSC (11, 12). The NRG1 
family of pleiotropic signaling proteins serve as epidermal growth factor (EGF)-like ligands for 
transmembrane tyrosine kinase receptors of the ErbB family and regulate multiple 
neurodevelopmental processes, including myelination and synaptic plasticity (13, 14). NRG1 
comprises a variety of isoforms, grouped into three main ‘types’. NRG1 type I and type II 
variants contain an immunoglobulin-like domain, whereas type III variants harbor a cysteine-
rich domain located N-terminal to the EGF-like domain, which serves as a second 
transmembrane domain (15). Thus, proteolytic processing in the extracellular domain by 
several proteases, including β-site amyloid precursor protein–cleaving enzyme1 (BACE1), 
releases the EGF-like domain in types I and II, resulting in paracrine signaling. In contrast, the 
EGF-like domain of type III variants remains membrane-anchored following BACE1 cleavage 
and has been implicated in juxtacrine signaling (16). MNs prominently express NRG1 type III 
isoforms during perinatal development (17-19). In addition, using an isoform-specific antibody, 
it has recently been reported that NRG1 type II is targeted to C-boutons (20). Nevertheless, 
NRG1 isoform-specific functions during C-bouton development have not been addressed. 
C-boutons are involved in diseases affecting MNs and spinal cord. Their reversible loss 
occurs following spinal cord injury (21). Although debated (22), C-boutons have also been 
reported to display pronounced changes in rodent and human MNs affected by amyotrophic 
lateral sclerosis (ALS, (12, 23-27). MN subtype-specific differences in vulnerability during 
disease conditions are driven by endogenous neuroprotective mechanisms linked to their 
synaptic activity and excitability, including those related with C-boutons; for example, blocking 
cholinergic neurotransmission via C-boutons results in increased neurotoxic misfolded SOD1 in 
MNs of an ALS mouse model (Saxena et al., 2013). Several C-boutons-associated proteins are 
also directly linked to ALS, as demonstrated for S1R (28-30) and VAPB (31). In addition, a 
mutation in the ErbB4 receptor has been identified as a genetic cause of ALS (32), suggesting a 
role of impaired NRG1 signaling in ALS pathophysiology. Another intriguing aspect of C-
boutons is the absence of this type of afferent synapses in ALS-resistant MNs of oculomotor 
(OCM) nuclei (Hellström et al., 2003; Gallart-Palau et al., 2014). 
Given the putative relevance of C-boutons for the understanding of spinal cord and MN 
pathology, and their potential as targets for therapy, a more detailed knowledge of C-bouton 
organization and reactivity to well-defined conditions of experimental injury is required. For 
instance, it has not been explored how the arrangement and stability of SSC-associated 
molecules (i.e., NRG1) are altered when afferent inputs are lost in target-deprived 
(axotomized) MNs and to which extent the ER-derived C-bouton-associated SSC is altered 
under these conditions. The effects of axotomy also extend to the perineuronal environment, 
including synaptic inputs and glial cells. Activated microglia following axotomy appear to 
displace synaptic terminals from the soma and dendrites, a phenomenon usually recognized as 
“synaptic striping” (33). C-boutons are also partially lost in response to axotomy (34), and a 
positive influence of C-bouton sites on recruitment of microglial processes has been observed 
in axotomized MNs (11). However, the role of microglia in C-bouton disruption and recovery in 
lesioned MNs is still poorly defined. 
Here, we systematically investigated the impact of nerve crush, irreversible peripheral 
nerve transection and pharmacological induction or attenuation of ER-stress on cholinergic 
presynaptic terminals, postsynaptic NRG1 clusters, and activation of perisynaptic glial cells. 
These studies revealed the involvement of ER-stress and microglial activation in pathological C-
bouton disruption. In addition, based on findings in transgenic mice overexpressing specific 
NRG1 isoforms, we show that juxtacrine NRG1 type III accumulates at C-boutons and may act 
as an organizer of SSC-like ER-plasma membrane contacts. In contrast, paracrine NRG1 type I 
promotes the differentiation of presynaptic components of C-type synapses, suggesting that 
distinct NRG1 isoforms govern the architectural and functional organization of C-boutons. 
 
Material and Methods 
Animals, surgical procedures and tissue preparation 
Wild-type (WT) mice (CD1 strain) were purchased from Harlan Laboratories (Castellar del 
Vallès, Barcelona, Catalonia, Spain). Mice were housed five to six per cage with permanent 
access to food and water under a 12-h light/12-h dark. All animal experimentation procedures 
were performed according to the European Committee Council Directive and the norms 
established by the Generalitat de Catalunya (published as a law in the Diari Oficial de la 
Generalitat de Catalunya [DOGC] 2073, 1995). All experiments were previously evaluated and 
approved by the Committee for Animal Care and Use of our Universities. 
Transgenic mice overexpressing full-length NRG1 type I (35), as well as HA-tagged full-
length NRG1 type III (HA-NRG1FL) and a HA-tagged variant that mimics NRG1 type III 
processing by BACE1 cleavage (HA-NRG1GIEF) were used and genotyped as described 
previously (36). 
All surgical manipulations were performed under anesthesia, with a combination of 
ketamine (100 mg/Kg) and xylazine (10 mg/Kg). To minimize suffering, mice were subjected to 
postoperative analgesia with intraperitoneally (i.p.) injected buprenorphine (0.05 mg/Kg). In 
one group of animals, the sciatic nerve at femoral level was exposed, transected and its 
proximal stump was ligated in order to prevent spontaneous reinnervation; in another group 
the sciatic nerve was crushed for 30 seconds using microforceps. 
For the pharmacological experiments, mice (postnatal day 60) has been used. Drug delivery 
regimes were i.p. injected based on published reports (26): methoctramine (Sigma-Aldrich, 
Madrid, Spain), 200 µg/kg, daily for 15 days; tunicamycin (Sigma-Aldrich), 1 mg/Kg in saline for 
2 days; and salubrinal (Alexis Biochemicals, San Diego, CA reconstituted at 2.6mM with PBS 
containing 0.1%BSA and 10% DMSO) 100 µl, daily , two days before the sciatic nerve axotomy 
and the next 7 days post-surgery. 
Electrical stimulation 
We used acupuncture steel needles (0.30x30mm, Acupuncture Shop Aps, Varde, 
Dennmark) as stimulation electrodes and a Cibertec stimulation unit (CS-20, Cibertec S.A., 
Madrid, Spain) at both sciatic nerve and spinal cord. 
The whole lumbosacral area and the leg were shaved and an incision through the skin and 
musculature made until visualizing the sciatic nerve. Then electrostimulation (5V at 10 Hz or 
100Hz) was applied with the stimulator unit. Electrical stimulation of the sciatic nerve causes 
action potentials in a retrograde direction which leads to a depolarization of the cell body of 
the MN in the spinal cord. Direct electrical stimulation of the spinal cord was performed using 
two acupuncture needles inserted immediately on each side of the dorsal spinal cord. Then, 
the electrical stimulation was applied with a stimulator unit (5 V at 10 Hz). Three animals in the 
same conditions but without electrical stimulation were used as sham controls. 
In both, sciatic and spinal cord stimulation, an electromyographic record of the food pad 
was used to check out the electrostimulation accuracy. For this purpose, the recording 
electrode was inserted into the foot pad and the reference electrode was inserted 
subcutaneously near the tail. 
In vitro slices 
The spinal cord, with the pia mater rapidly removed and immersed in cold (0–4 ºC), 
oxygenated (95% O2/5% CO2) artificial cerebrospinal fluid (ACSF), containing (in mM): NaCl, 
130; NaHCO3, 26; MgCl2, 2; NaPO4, 1.25; CaCl2, 2; KCl, 3; glucose, 10. In some experiments, 
isolation of spinal cords were performed with sucrose-ACSF (in mM): NaHCO3, 26; MgCl2, 2; 
NaPO4, 1.25; CaCl2, 0.5; KCl, 3; sucrose, 218, and later transferred to normal ACSF (37). Some 
experiments were performed in a 0 Ca2+ ACSF; in this case, 4 mM EGTA was added. The spinal 
cord was hydraulically extruded by applying pressure on a syringe filled with ACSF placed on 
the caudal opening of the vertebral canal as described (38). Prior to excision, the animals were 
briefly perfused transcardially with ice-cold oxygenated (95% O2, 5% CO2) ACSF. Isolated 
lumbar segments were rapidly sliced (300-400 μm transversal sections) with a McIlwain tissue 
chopper tissue. The slices were subsequently transferred (or not) to a storage perfusion 
chamber filled with oxygenated normal ACSF, until their fixation in 4% paraformaldehyde (PF) 
at the desired experimental time. 
Multiple fluorescent labeling and confocal microscopy 
Tissue samples were obtained from anaesthetized mice, transcardially perfused with 4% PF 
in 0.1 M phosphate buffer (PB), pH 7.4. Human spinal cord samples (4% PF fixed) were 
obtained from the Banc de Teixits Neurològics de l’Hospital Universitari de Bellvitge (Dr. Isidre 
Ferrer, Barcelona, Catalonia, Spain). Tissues from animal species other than rodents were also 
fixed in 4% PF. Samples were post-fixed overnight in the same fixative at 4°C, and then 
cryoprotected with 30% sucrose in 0.1 M PB containing 0.02% sodium azide. Transverse 
cryostat sections (16-μm thick) were collected on gelatin-coated glass slides. 
Sections were then permeabilized with phosphate-buffered saline (PBS) containing 0.1% 
Triton X-100 for 30 minutes, blocked with either 10% normal goat serum or normal horse 
serum in PBS for 1 h at room temperature, and then incubated overnight at 4 °C with an 
appropriate primary antibody mixture. The primary antibodies used are indicated in Table 1. 
Once previously washed with PBS, sections were incubated for 1 hour with a combination 
of appropriate secondary fluorescent antibodies labeled with one of the following 
fluorochromes (1/500): Alexa Fluor 488, Alexa Fluor 546, (Molecular Probes, Eugene, OR, 
United States), Cy3, or Cy5 (Jackson Immuno Research Laboratories, West Grove, PA, United 
States). Finally, the spinal cord sections were labeled with blue fluorescent NeuroTrace Nissl 
staining (1:150; Molecular Probes) and mounted using an anti-fading medium containing 0.1 M 
Tris-HCl buffer (pH 8.5), 20% glycerol, 10% Mowiol, and 0.1% 1,4-diazabicyclo[2,2,2]octane. For 
ErbB visualization, some sections were processed using the tyramide signal amplification (TSA), 
following the procedure recommended by the manufacturer (ThermoFisher, Waltham, MA). 
Concerning anti-NRG1 antibodies, in our hands, the best commercially available antibody 
that can be used to visualize NRG1 at C-boutons is the pan-NRG1 antibody sc-348 (Santa Cruz 
Biotechnology, Dallas, TX). As this product has been recently discontinued, we looked for other 
alternatives. Only the rabbit anti-NRG1 type III (extracellular, ANR113, from Alomone, 
Jerusalem, Israel) gives a positive labeling at C-bouton sites, but this was weaker than that 
obtained with sc-348. The mouse monoclonal anti-NRG-CDR type III antibody (MABN534, from 
Millipore, Temecula, CA) is also able to dimly detect C-bouton NRG1 (Suppl. Fig. 1). 
Retrograde tracing of MNs was performed with fluorescent-labeled cholera toxin-B subunit 
(CTB-AlexaFluor 555; Molecular Probes) at 1 μg/μl in PBS. Tracer (5 μl) was injected in leg 
muscles by means of glass capillary tubes attached to a Hamilton syringe. Animals were 
perfused 24 h later, and tissues were processed for immunolabeling as above described. 
The slides were then examined under a FluoView FV-500 or FluoView FV-1000 Olympus 
laser-scanning confocal microscopes (Olympus, Hamburg, Germany). The MNs were imaged 
after obtaining optical sections (0.5 or 1 μm) of cell bodies. Digital images were analyzed with 
either Visilog 6.3 software (Noesis, Orsay, France) or ImageJ software (US National Institutes of 
Health, Bethesda, MD, USA). For colocalization analysis, the ImageJ plugin developed by Pierre 
Bourdoncle (bourdoncle@ijm.jussieu.fr) was used. 
Immunolabeled profiles of NRG1 and of the different protein markers examined were then 
manually counted on the screen for each MN soma. In axotomy experiments, we only analyzed 
cell bodies located in pes 9 region of L6 spinal cord segment, which corresponds to the sciatic 
motor column, according to (39) The area and perimeter of MN somata, and microglial profiles 
covering MNs were also manually measured. The number of synaptic boutons contacting 
activated microglia in axotomized MNs was evaluated by image analysis (ImageJ). After 
application of the outline tool on binarized Iba1 images, these were merged with those 
corresponding to binarized synaptic boutons: the number of boutons contacting perisomatic 
microglial profiles was manually counted. In some cases, three-dimensional reconstructions 
were performed using Bitplane (Imaris, Bitplane, CT, USA) on 0.5-μm thick Z step obtained with 
the confocal microscope. The digital images were edited using FV10-ASW 3.1 Viewer 
(Olympus) and Adobe Photoshop CS4 (Adobe Systems Inc, San Jose, CA). 
Electron microscopy 
Some of the animals were perfused either with 1% PFA and 1% glutaraldehyde in 0.1 M PB 
(pH 7.4) for conventional electron microscopy or with 4% PFA. Dissected tissues were postfixed 
in 1% OsO4 and processed for Embed 812 embedding according to standard procedures. 
Ultrathin sections were counterstained with uranyl acetate and lead citrate. 
Statistical analysis 
The data are expressed as means ± SEM. The statistical analysis was assessed by either the 
Student’s t-test or either one-way or two-way analysis of variance (ANOVA) followed by post-
hoc Bonferroni’s test. The level of significance was established at p < 0.05. 
 
Results 
Molecular architecture of C-boutons in vertebrate spinal MNs 
In agreement with our previous studies (11), we corroborated that ventral horn α-MNs in 
adult mouse spinal cord are innervated by large, cholinergic (VAChT-positive) presynaptic 
terminals, which juxtapose a highly organized postsynaptic compartment harboring a specific 
set of distinct proteins, including M2 AChRs, Kv2.1 K+ channels, S1R, and NRG1. Postsynaptic 
regions delimited by NRG1 were often aligned with several VAChT positive terminal bulbs, 
indicating that individual C-terminals form branches that share a common postsynapse (Fig. 
1a-d). Expression of the NRG1 receptor ErbB2 and its phosphorylated form colocalized with 
VAChT in the presynaptic compartment of C-boutons (Fig. 1e). 
In addition to mouse spinal cord, we observed the characteristic punctate accumulation of 
NRG1 in the postsynaptic compartment of C-boutons in all vertebrate species analyzed, 
including frog, lizard, chicken, pig, and human (Suppl. Fig. 2a-g), consistent with evolutionary 
conserved NRG1 functions in C-type synapses in the vertebrate lineage. 
Upon inspection by electron microscopy (EM), large afferent nerve terminals were 
identified as C-boutons if they coaligned with a postsynaptic SSC, a hallmark for this type of 
synapse (Fig. 2a-d). Large aggregates of spherical or flattened clear synaptic vesicles were 
often concentrated at active zone-like sites close to the presynaptic PM, whereas presumably 
endocytic “coated” vesicles tended to accumulate at the most peripheral areas of terminals 
(Fig. 2b). Large membrane-bound vacuoles sequestering synaptic vesicles were also frequently 
seen within the presynaptic compartment, resembling either late endosomes/multivesicular 
bodies or phagosomal structures (Fig. 2c). To trace endocytic compartments of MN, 
intramuscular injections were performed using either fluorescent cholera toxin B or the Hc 
fragment of tetanus toxin. Although both tracers were extensively incorporated into the 
vacuolar system of MN somata, no association was found between labeled compartments and 
NRG1-marked postsynaptic regions of C-boutons (Suppl. Fig. 3). 
MN stimulation alters C-bouton-associated NRG1 clusters 
We next ask whether physiological or pathological changes in MN activity could affect C-
bouton-associated NRG1 expression domains. Electrical stimulation of sciatic nerve results in 
antidromic propagation of action potentials and MN cell body depolarization, whereas 
electrical stimulation adjacent to the spinal cord causes orthodromic activation of MN axons 
that can be assessed by EMG recordings of distal leg and foot muscles. Moderate antidromic 
stimulation (10 Hz, 60 min) produced a modest increase in the size of both pre- and 
postsynaptic C-bouton compartments delineated by VAChT and NRG1, respectively (NRG1 
cluster size in μm2: contralateral, 4.26 ± 0.22, n = 28 MNs; ipsilateral, 5.48 ± 0.24, n = 37 MNs; 
p < 0.05). Cholinergic transmission at C-boutons is mediated by M2 AChRs, which can be 
pharmacologically targeted by treatment with the M2 agonist oxotremorine. Similar to 
antidromic stimulation, oxotremorine treatment caused an increase in size of postsynaptic 
NRG1 clusters (NRG1 cluster size in µm2: saline, 4.37 ± 0.18, n = 103 clusters; oxotremorine, 
5.97 ± 0.37, n = 62; p < 0.01). 
In contrast to moderate stimulation, pathologic antidromic stimulation (100 Hz, 60 min) or 
direct orthodromic spinal cord stimulation at lower frequency and shorter time period (10 Hz, 
30 min) resulted in a severe depletion of NRG1 clusters, whereas VAChT-positive terminals 
were largely spared (Fig. 3a-k). Examination by EM (Fig. 3j) showed that, as a consequence of 
extreme spinal cord stimulation, the SSC was disrupted in many C-boutons, and SSC remnants 
in identifiable C-boutons had a shortened contact area with the postsynaptic membrane; in 
line with SSC disruption, we observed an increased number of vacuoles at variable sizes, 
multivesicular bodies and vesicles in subsynaptic regions of the MN cortical cytoplasm. 
ER-disruption was largely confined to cortical regions of MN cell bodies, but was absent 
from Nissl-like ER stacks located in more central cytoplasmic areas (Fig. 3j). We conclude that 
pathological exacerbation of synaptic activity at C-boutons heavily impacts on the stability of 
postsynaptic SSCs. This notion was supported by a dramatic loss of SSC-associated NRG1 
clusters at C-boutons in an in vitro acute spinal cord slice preparation maintained in ACSF. Even 
after reducing the preparation time from anesthesia to slicing and paraformaldehyde fixation 
to ~9 min (with or without ulterior recovery in an oxygenated-superfusion slice chamber), 
most MNs were completely devoid of NRG1-positive puncta. In those few cases, in which 
NRG1 clusters persisted, they appeared heavily fragmented and dispersed. Small-sized VAChT 
puncta were still present juxtaposed to a fraction of de-clustered NRG1-containing SSC 
remnants (Fig. 3l-s). These findings identify an extreme SSC instability as a major component of 
adult MN vulnerability in response to slicing procedures, most likely due to their large dendritic 
arbor (40). While similar experiments performed with Ca2+-free CSF did not improve the 
preservation of NRG1 clusters (Fig. 3t), we suggest that massive Ca2+ release from intracellular 
Ca2+ stores is sufficient to disrupt SSC integrity in cortical areas of MN cell bodies. 
To further analyze the dependence of C-boutons and their associated NRG1 clusters on ER 
integrity in vivo, we induced ER-stress by parenteral administration of tunicamycin (26). The 
effectiveness of drug administration was assessed by the demonstration that BiP was 
upregulated in MN somata (BiP intensity in arbitrary units: saline, 116.38 ± 6.76, n = 58 MNs; 
tunicamycin, 217.10 ± 6.42, n = 57 MNs; p < 0.001). EM analysis confirmed disrupted Golgi and 
ER membranes (not shown). Concomitant with widespread ER stress, tunicamycin treatment 
also disrupted SSC-associated NRG1 clusters (NRG1 cluster size in µm2: saline, 3.11 ± 0.12, n = 
278 clusters [from 58 MNs]; tunicamycin, 2.42 ± 0.06, n = 444 clusters [from 57 MNs], p < 
0.001), and these postsynaptic changes were matched by an equivalent but attenuated 
response at the corresponding VAChT-delimited presynaptic terminal (VAChT cluster size in 
µm2: saline, 3.73 ± 0.13, n = 514 clusters [from 58 MNs]; tunicamycin, 3.19 ± 0.13, n = 226 
clusters [from 57 MNs]; p < 0.01). Thus, we conclude that pharmacologically-induced ER-stress 
diminishes the integrity of SSC-associated NRG1 clusters, which in turn affects the size of 
presynaptic C-boutons. 
Glial reactivity and C-bouton plasticity after reversible and irreversible axonal interruption 
Distal axon transection leads to rapid and drastic changes in MNs and their synaptic and 
glial environment (41). We recently showed that C-boutons of axotomized MNs rapidly attract 
microglial processes (11). Here, we extended these findings by performing a long-term analysis 
in both reversible (crush) and irreversible (axotomy) axonal interruption paradigms (Fig. 4a-d). 
A rapid microglial and astroglial recruitment to MNs occurred 1-3 days after axotomy, in 
concomitance with C-bouton disruption. Most microglial profiles interacted with NRG1-
positive C-boutons 1 day after nerve injury, but subsequently the number of microglia 
interacting with NRG1-positive C-boutons rapidly declined (Fig. 4e-i, Suppl. Fig. 4 and movie). 
Importantly, the disruption of VAChT-labeled presynaptic terminals was temporally dissociated 
from the disorganization of postsynaptic NRG1-clusters. Whereas at 7 days after axotomy we 
observed a loss of 72% of VAChT profiles, the number of postsynaptic NRG1 clusters was only 
reduced by 32%. This indicates that the elimination of the presynaptic component of C-
boutons implies a disorganization and subsequent reorganization of their postsynaptic SSC-
associated NRG1 clusters. A recovery of some C-boutons was seen 15 days after axotomy, 
which occurred in conjunction with a sustained decline of microglial recruitment. However, an 
opposite profile was seen for astrogliosis, which, after a transient decline, is again triggered 30 
days post irreversible nerve injury (Fig. 4b). Regenerated VAChT-positive C-boutons displayed a 
marked, but transient, reduction in size of postsynaptic NRG1 clusters (Fig.4b-d). To further 
assess the involvement of microglia in the elimination of the presynaptic compartment of C-
boutons, we compared the juxtaposed expression of VAChT and NRG1 in individual synapses in 
the presence and absence of nearby Iba1-labeled microglial processes 14 days postaxotomy. 
NRG1 clusters contacting microglia showed VAChT depletion, whereas those in the absence of 
microglial processes exhibited a positive VAChT signal (Fig. 4j,k). Together, we conclude that 
the axotomy-mediated loss of C-boutons is a consequence of a selective microglial recruitment 
to these synaptic sites, in concordance with the ability of microglia to engulf synaptic inputs 
during normal and pathological conditions (42, 43). 
The pronounced atrophy seen in axotomized non-reinnervating MNs, was less severe after 
nerve crush (Fig. 4a-d). Moreover, the severe and long-term astroglial reaction following nerve 
transection was also significantly milder after crush. Compared to irreversible axotomy, an 
improvement in the restoration of C-bouton density was present 120 days after crush, 
however, this was no longer sustained. 
A further indication of a microglia-mediated removal of presynaptic terminals following 
axotomy was obtained from ultrastructural analysis (Fig. 5a-k). We noticed that a considerable 
number of axo-somatic presynaptic terminals showed degenerative changes; some of these 
terminals, which often appeared in close proximity to microglial cells, displayed a complete 
disintegration (Fig 5f and h). However, due to the advanced stage of degeneration, it was 
impossible to unambiguously identify the morphological subtype of affected synaptic boutons. 
Nevertheless, in some cases remnants of postsynaptic SSCs were still present adjacent to 
microglia-covered MN surface areas (or to degenerating synapses), indicating that those 
correspond to “denervated” C-bouton sites, which underwent degeneration post-axotomy 
(Fig. 5g and i-k). Based on these data, we conclude that, at least in part, microglia-mediated 
elimination of C-boutons following axotomy causes a rapid disintegration of presynaptic 
compartments. This observation contrasts the generally accepted concept that synaptic 
elimination from axotomized MNs results from the detachment of presynaptic terminals from 
perykaria by activated microglia, which physically separate pre- and post-synaptic elements in 
the absence of synaptic degeneration (“synaptic striping”, (33)). The exact role of activated 
microglia in the destruction of synaptic terminals is difficult to assess here. However, PM 
apposition of microglia to SSC remnants at sites devoid of synaptic boutons most likely marks 
areas previously occupied by C-boutons, and this finding is consistent with a more rapid 
postaxotomy loss of VAChT-positive puncta compared to their postsynaptic counterpart as 
defined by NRG1 immunolabeling. 
Neuronal damage induced by peripheral or central axonal injury comprises unfolded 
protein response and ER-stress that can promote a regenerative response or apoptotic cell 
death (44, 45). Salubrinal provides neuroprotection by inhibition of Pi-eIF2 
dephosphorylation and ER-stress (46) and salubrinal treatment results in attenuation of 
microgliosis and neurodegeneration in SOD1G93A mice (47). Using a similar treatment protocol 
we found that salubrinal administration significantly reduced BiP elevation and nearly 
abolished the massive microglial recruitment to MN somata 7 days post-axotomy (Fig 6a-p). 
Moreover, the loss of presynaptic VAChT and postsynaptic NRG1 that concomitantly occurred 
in axotomyzed MNs was strongly attenuated by salubrinal. This indicates that unfolded protein 
response is coupled with microglial activation and synaptic loss in distally lesioned MNs. 
Distinct NRG1 isoforms mediate specific pre- and postsynaptic functions at cholinergic C-
boutons 
Transgenic mice with Thy1.2 promoter-mediated neuronal overexpression of distinct NRG1 
isoforms have previously been employed to study axonal control mechanisms during 
myelination of spinal MNs (35, 36). Considering NRG1 as a prominent and spatially restricted 
component of C-boutons, we took advantage of these mouse lines to examine NRG1 isoform-
specific functions in C-bouton development and architecture. These studies included 
transgenic mice which overexpress full-length NRG1 type I (35), N-terminally HA epitope-
tagged full-length NRG1 type III (HA-NRG1FL) or a HA-tagged NRG1 type III variant that mimics 
the product of BACE1 cleavage in the juxtamembrane ‘stalk’ region (HA-NRG1GIEF; (36), which 
separates an N-terminal (EGF-like domain-containing) transmembrane protein from the C-
terminal ICD (Suppl. Fig. 5). 
First, we performed simultaneous fluorescent immunostainings for the N-terminal HA-tag 
and either the C-terminal ICD of NRG1 or the C-bouton postsynaptic markers S1R, Kv2.1 and 
M2 AChR, in conjunction with presynaptic VAChT on spinal cord sections (Fig. 7a-f). Samples 
from HA-NRG1FL mice showed highly overlapping immunostaining for the HA-tag and the ICD 
on the surface of MN cell bodies, which was frequently associated with presynaptic VAChT-
positive C-boutons (Fig. 7a). These findings are consistent with the accumulation of 
unprocessed NRG1 type III at postsynaptic sites of C-boutons. To assess possible consequences 
of the postsynaptic accumulation of NRG1 type III on the organization of C-type synapses, we 
performed an examination of HA-NRG1FL mice by EM. Remarkably, we observed an 
accumulation of abnormally expanded surface-associated ER membranes, which were 
arranged like redundant SSCs (Fig. 9a). As the number of cholinergic C-boutons contacting MN 
somata was not altered (Fig. 8a), only a fraction of plasma membrane presenting apposed ER 
membranes was associated with afferent synaptic C-boutons in HA-NRG1FL mice. We also 
analyzed whether the pattern of S1R and Kv2.1, two molecules that normally concentrate in C-
bouton-associated SSCs, were altered in HA-NRG1FL mice. We found that both, S1R and Kv2.1, 
were notably increased, displaying a similar pattern to that found for NRG1 type III detected by 
HA staining (Fig. 7b and e, and 8d and e). Thus, the induction of redundant SSC-like membrane 
compartments by NRG1 type III overexpression was linked to an increased production and 
insertion of other SSC-associated partner molecules, such as S1R and Kv2.1. Nevertheless, a 
more detailed examination revealed that although S1R and NRG1 were closely associated, they 
did not occupy identical micro-domains (Fig. 8c-d), very similar to their configuration in C-
boutons from WT mice (11). In contrast, a tight co-localization between NRG1 and Kv2.1 was 
observed (Fig. 7e). Importantly, expression of M2 muscarinic receptors, which presumably 
reside mainly in the postsynaptic membrane, also expanded beyond synaptic areas, as defined 
by the absence of VAChT-positive terminals, in HA-NRG1FL mice (Fig. 7f and 8c). Together, the 
redundancy and enlargement of SSC-like structures in HA-NRG1FL mice suggest that full-length 
NRG1 type III acts as an organizer of ER-membrane contacts, including SSCs, in MNs. These 
findings also indicate that SSCs are involved in organizing the size and molecular layout of the 
postsynaptic membrane, whereas SSC architecture has no major direct effects on presynaptic 
elements of C-boutons. 
To address a specific role of the cytoplasmic ICD in organizing SSC architecture in C-
boutons, we next investigated HA-NRG1GIEF mice. Although extensive HA-NRG1GIEF expression 
was observed in MN cell bodies and dendrites, the BACE1-processed variant of NRG1 type III 
was completely excluded from C-bouton sites. This was unambiguously corroborated when 
HA-tag detection was combined with antibodies against VAChT and pan-NRG1 (sc-348) to 
localize C-boutons (Fig. 7g). Consistent with this finding, no expansion of SCC structures, S1R 
and M2 expression domains was observed in HA-NRG1GIEF mice (not shown). Taken together, 
these data strongly suggest that the C-terminal ICD is required for SSC accumulation of NRG1 
type III and that full-length NRG1 type III exerts specific postsynaptic, SSC organizing functions 
in spinal MNs. 
NRG1 type I shares the same ICD with NRG1 type III, but lacks a second transmembrane 
domain, therefore BACE1 processing results in shedding of the N-terminal EGF-like domain and 
paracrine signaling. To identify possible consequences of enhanced NRG1 type I-mediated 
paracrine signaling on C-bouton development, we next examined transgenic mice with Thy1.2 
promoter-driven NRG1 type I overexpression (NRG1typeI) in spinal MNs (35). As this transgene 
lacks an N-terminal HA-tag, a specific immunostaining for transgene-derived NRG1 type I could 
not be performed. However, immunostaining for the ICD produced an extensive signal at the 
MN surface of NRG1typeI mice (Fig. 7h) analogous to that obtained in HA-NRG1FL mice. 
Moreover, immunostaining for M2 AChRs showed their enlarged distribution on the MN 
surface, similar to that observed in HA-NRG1FL mice (Fig. 7i). However, in stark contrast to HA-
NRG1FL mice, VAChT immunostaining revealed a profound increase in the number and size of 
presynaptic cholinergic terminals innervating the MN surface (Fig. 8a, b). Nevertheless, we 
found no concomitant increase in the number of ChAT-positive V0C neurons in NRG1
typeI mice 
(VOC interneuron numbers per section, expressed as mean ± SEM: WT, 2.37 ± 0.32, n = 8 
sections; NRG1typeI 1.74 ± 0.32, n = 14 sections; p > 0.05), strongly suggesting that C-bouton 
synaptogenesis was abnormally stimulated in NRG1typeI mice. Many of these VAChT-positive 
puncta were associated with neighboring postsynaptic S1R-positive patches, which did not 
overlap with pan-NRG1 signal, in the same way as occurs in WT (Fig. 7h). In addition, S1R 
clusters in NRG1typeI mice were not enlarged when compared with those in WT (Fig. 8d). This is 
in contrast to that was observed in HA-NRG1FL mice, in which surface-associate S1R labeling is 
largely expanded together with NRG1. Kv2.1 clusters were not detected in NRG1typeI mouse 
MNs (Fig. 8e). 
Ultrastructural examination confirmed the presence of enlarged presynaptic terminals on 
the MN soma surface, matching only partially with post-synaptic SSC; moreover, the amplified 
formation of SSC-like ER-plasma membrane contacts in HA-NRG1FL mice was not observed in 
NRG1typeI mice (Fig. 9b). This suggests that NRG1 type I is mainly targeted to the MN plasma 
membrane, whereas NRG1 type III is preferentially located to C-bouton SSCs. As Kv2.1 is a 
protein specifically linked to ER-plasma-membrane junctions (e.g. at SSCs) (48), its expanded 
or, alternatively, reduced expression detected in HA-NRG1FL or NRG1typeI mice, respectively, is 
consistent with this interpretation. A summary of idealized C-bouton phenotypes in NRG1 
transgenic mice is depicted in Fig. 9c. 
C-boutons and associated NRG1 clusters are absent in ALS-resistant OCM (abducens cranial 
nerve [CN] VI) MNs (12), but present in other brainstem motor nuclei. Therefore, we next 
examined the impact of NRG1 overexpression in brainstem MNs of NRG1 transgenic mouse 
lines (Suppl. Fig. 6a-f). Consistent with our above findings, non-OCM MNs (facial [CNVII], 
hypoglossus [CNXII] and ambiguous [CNX] nuclei) displayed similar effects of NRG1 
overexpression on C-bouton structure as described for spinal cord MNs, including an increased 
number of VAChT-containing synaptic afferents in NRG1 type I overexpressing transgenic mice 
(Suppl. Fig. 6c). NRG1 labeling patterns in OCM MNs of NRG1typeI HA-NRG1FL mice were also 
comparable to those observed in non-OCM MNs. However, as in WT (Suppl. Fig. 6d), we never 
observed VAChT-positive C-boutons on the surface of transgenic OCM MNs (Suppl. Fig. 6e-f). 
These findings strongly suggest that NRG1 type I promotes C-bouton synaptogenesis also at 
non-OCM MNs, but that additional factors are required to promote cholinergic synaptogenesis 
in OCM MNs. 
Altogether, these findings suggest that: 1) full-length NRG1 type III acts as a specific 
organizer of postsynaptic SSC-like membrane compartments without a major impact on the C-
bouton presynaptic counterpart, 2) NRG1 type I promotes presynaptic C-bouton 
synaptogenesis, with no influence on biogenesis or molecular architecture of co-aligned SSC, 
and 3) there is partial independence of pre- and postsynaptic C-bouton development. Thus, 
specific signaling functions related to the distinct spatial arrangement of NRG1 isoforms are 
involved in the complex matching of pre- and postsynaptic elements at C-boutons. 
 
Discussion 
To provide a better understanding of the role of C-boutons and associated NRG1 assemblies in 
MN diseases, we describe here novel aspects of their biology and responses when subjected to 
distinct paradigms of experimental MN injury. Stimulation and ex vivo slicing experiments 
revealed that C-bouton-associated NRG1 assemblies are extremely sensitive to acute cellular 
stress. This probably reflects their tight association with SSCs, a specialized form of highly 
dynamic cortical ER, which is closely apposed to the postsynaptic plasma membrane of C-
boutons. In fact, rapid and reversible ER fission occurs after neuronal depolarization, and 
synaptic activity modulates ER structure via Ca2+ transients (49, 50). In addition, Kv2.1 clusters 
in ER-plasma-membrane junctions, which are homologous structures to SSCs, are highly 
dynamic and unstable when exposed to moderate stress (48). We report here that moderate 
levels of either electrical or chemical stimulation induce an enlargement of VAChT-labeled 
presynaptic terminals and their associated postsynaptic NRG1 clusters. This is in congruence 
with data reported in the context of electrical stimulation of proprioceptive afferents to MNs 
(51). The dependence of NRG1 clusters on the structural integrity of cortical ER was further 
confirmed by induction of ER-stress with tunicamycin, which severely disrupted NRG1 clusters 
without affecting the number and size of VAChT-positive terminals. This observation is distinct 
from our findings in MNs following axotomy in which the dispersion of NRG1 clusters at C-
boutons takes place at a slower time scale compared to the loss of presynaptic terminals, the 
latter presumably being mediated by reactive microglia. 
We also confirm our previous observations that C-boutons are preferred sites to be 
contacted by reactive microglia in injured MNs post-axotomy (11) and provide new data 
concerning the involvement of microglial cells in synaptic removal in this pathological 
condition. At present, the molecular substrate of this positive chemotactic effect is unknown. 
NRG1/ErbB signaling promotes microglial chemotaxis in vitro and in spinal cord dorsal horn 
after peripheral nerve injury (52, 53), and antagonizing NRG1 signaling results in a reduction of 
microgliosis and MN death in mutant SOD1 ALS mice (54). Thus, whether NRG1/ErbB signaling 
also operates during C-bouton-directed microglial sensing after axotomy should be further 
explored. 
We found no evidence for the engulfment of presynaptic elements by microglial processes 
recruited in the vicinity of axotomyzed MNs. This is in accordance with the classical description 
of microglial activation and synaptic removal that occurs during the response of MN cell bodies 
to axotomy (33). However, in contrast to these studies, we unambiguously observed 
degenerating presynaptic boutons contacting lesioned MNs in close association with 
perineuronally-recruited microglia. This suggests an active role of microglia in the 
disintegration of presynaptic terminals by means of a target-directed toxic mechanism instead 
of bulk phagocytosis. Activated microglia produce free oxygen radicals, nitric oxide, proteases 
and cytokines (55), all of which could be neurotoxic in a local microenvironment and induce 
extrinsic apoptosis (56) or extracellular digestion (“exophagy”) of synaptic debris (57). In 
congruence with this idea, superoxide ions produced by microglial cells induce apoptotic death 
of Purkinje neurons in organotypic slice cultures (58), and macrophage-derived TNFα signals 
developmental MN death (59). Since axons can activate degenerative/apoptotic molecular 
pathways without resulting in cell death of the parent neuron (60), it is plausible that a similar, 
spatially restricted mechanism operates at presynaptic axon terminals (61). 
Our data suggest that NRG1 ‘declustering’ is related to a microglia-dependent disruption of 
cholinergic presynaptic terminals, in conjunction with ER-stress/reorganization inherent to a 
chromatolytic reaction. We demonstrate that C-bouton disruption in axotomyzed MNs is 
prevented when ER-stress or microglial activation is inhibited by salubrinal treatment. Our 
data also indicate that removal of afferent terminals, including C-boutons, precedes 
postsynaptic NRG1 declustering and removal. This interpretation is supported by the presence 
of activated microglia in close proximity to denervated, SSC-containing postsynaptic sites of 
MN somata. Resting microglia perform specific and transient mutual contacts and serve as a 
vigilant surveyor of synaptic activity. During pathological conditions, microglial processes 
extensively enwrap synaptic boutons that will be later removed (42). However, in agreement 
with a classic study (33), we found no ultrastructural evidence for the engulfment of embraced 
axon terminals into phagosomes of activated microglia adjacent to axotomyzed MN somata. 
Axonal regeneration following nerve crush frequently results in restored peripheral nerve 
function 6-8 weeks after injury (34, 62). Our analysis of cholinergic C-boutons are comparable 
with previous studies (34) showing their recovery after either irreversible transection or crush. 
However, to which extend their function is restored is currently unclear. In fact, the size of 
postsynaptic NRG1 clusters was not fully restored after irreversible nerve transection, but 
almost completely reestablished after (more permissive) injury following nerve crush. This is 
another example of the relative independence of pre- and postsynaptic components of C-
boutons during development and adult plasticity. C-bouton density in MNs also depends on 
competition with other types of synapses in an activity and space-dependent manner (63). For 
instance, the loss of vesicular glutamate transporter 1 (VGLUT1)-containing boutons (derived 
from proprioceptive sensory afferents) from axotomyzed MNs is not restored during 
peripheral regeneration (34). This indicates that peripheral nerve injury induces permanent 
deficits in the function and plasticity of central synaptic connections, but the inability to 
restore proprioceptive afferent may favor regeneration of cholinergic inputs to lesioned MNs. 
Our findings in NRG1 transgenic mice demonstrate that altered expression levels (and most 
likely signaling activities) of NRG1 isoforms differentially affect molecular and structural 
features of C-boutons. These results reveal a previously unknown role of distinct NRG1 
isoforms as selective organizers of pre- and post-synaptic components of cholinergic C-
boutons at the receptive somatodendritic compartment of spinal MNs and adds to established 
functions of NRG1 in the neuromuscular system, such as: 1) differentiation and survival of 
Schwann cells (64); 2) myelination of peripheral axons (35, 36, 65, 66); 3) terminal Schwann 
cell-mediated remodeling of neuromuscular junctions (19); and 4) regulation nicotinic AChRs 
clustering at the neuromuscular junction (67). 
Specifically, we show that NRG1 type III serves as a postsynaptic SSC organizer with no 
major impact on the formation or structure of presynaptic VAChT-positive terminals. In 
contrast, NRG1 type I stimulates a substantial increase in the number and size of cholinergic 
inputs without driving the development of an equally enlarged SSC. The exact mechanism and 
functional consequences of NRG1 type I-mediated effects on presynaptic terminal growth and 
NRG1 type III-induced SSC enlargement are currently unknown and require further 
investigation. ER-plasma membrane contacts are involved in calcium homeostasis by means of 
a mechanism referred to as “store operated calcium entry” (SOCE). An essential protein in this 
process is STIM1, which, when overexpressed, induces multilayered stacks of cortical ER (68) 
comparable to those produced in MNs of NRG1 type III overexpressing mice. In our study, 
enlarged ER-derived planar stacks displayed distinct subdomains that, in addition to NRG1, 
were enriched in SR1 and Kv2.1, as expected for redundant SSCs. It is interesting to note that 
the sole overexpression of Kv2.1 is sufficient to induce ER-plasma-membrane junctions (48). 
Since S1R plays a role as a SOCE regulator in a variety of systems, this suggests that SSC at C-
boutons serve as a Ca2+ microdomain and that NRG1 type III-mediated changes of SSC 
architecture could recruit STIM1 functions, thereby shaping the temporal and spatial fine-
tuning of intracellular Ca2+ at this specific site (69). Stimulation of both NRG1 type I and type 
III-mediated signaling impacts on the accumulation of M2 AChRs at the postsynaptic plasma 
membrane. Thus, the concept of NRG1-regulated functional interactions of M2 AChRs with 
other postsynaptic components of C-type synapses, e. g. Kv2.1 potassium channels (7) requires 
further investigations. Kv2.1 channels form highly dynamic clusters on the plasma membrane 
of cortical neurons (70), may contribute to homeostatic adaptation of MN excitability during 
pathologic conditions, and axotomy results in a loss of Kv2.1 clusters at C-boutons (71). Of 
note, NRG2, which is structurally related to NRG1 type I, accumulates in close proximity to 
Kv2.1 clusters in the plasma membrane atop intracellular SSCs in cortical interneurons and 
NRG2/ErbB4 serve a negative feedback loop that controls NMDA function (72). Moreover, 
NRG1 type I colocalizes with NRG2 and Kv2.1 channel clusters in cultured hippocampal 
neurons (20). These findings indicate that NRG isoforms constitute a diverse set of spatially 
compartmentalized postsynaptic signaling molecules that play an important role during C-
bouton differentiation. Possible additional functions in the modulation of plasma 
membrane/SSC interactions and chemical transmission at C-boutons and cortical synapses will 
require further studies. 
Altered spinal cord expression of NRG1 isoforms occurs in a SOD1 ALS mouse model (73), 
and loss of C-bouton-associated NRG1 assemblies in this mouse model and in human ALS have 
been observed (12, 74). Similarly, increased activation of ErbB receptors was found in 
inflammatory microglia in ALS mouse models and human patients (73, 75). Recently, NRG1 
signaling was directly targeted in SOD1-ALS mice by virus-mediated delivery of NRG1 type III to 
the spinal cord, which resulted in an extended survival time and reduced C-bouton loss, 
whereas NRG1 type I expression had no effect (74). NRG1 type I overexpression confined to 
the muscle promoted axonal collateral sprouting and muscle reinnervation, but failed to 
improve clinical outcome (76). On the other hand, blocking NRG1 signaling reduced microglial 
activation and slowed disease progression (54). Taken together, these data indicate that 
pleiotropic NRG1 activities may account for the variable and to some extend discrepant 
outcomes when analyzed in the context of distinct therapeutic approaches. 
In conclusion, our study identifies plastic C-bouton changes in well-defined experimental 
models of MN injury and reveals previously unknown functions of distinct NRG1 isoforms in C-
bouton architecture. Our data provide a refined framework for the involvement of C-boutons 
in the pathophysiology of MN diseases, such as ALS. Since C-boutons regulate MN excitability, 
contribute to MN vulnerability and orchestrate neuroinflammatory glial responses after nerve 
injury, the targeting of C-bouton-embedded signaling modules, such as the NRG1/ErbB axis, 
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Figure 1. C-boutons on normal spinal cord MNs (visualized by Nissl staining, blue) after double 
fluorescent immunolabeling. a) A MN soma showing the concentration of M2 AChR (green) in 
close apposition with VAChT-labeled synaptic terminals (red); in the enlarged insets the 
displacement of the presynaptic VAChT-signal with respect to the postsynaptic M2 AChR 
labeling can be seen. b) MN soma showing the close relationship of S1R (green) with VAChT-
labeled synaptic terminals (red); note in the insets the displacement of S1R signal respect to 
VAChT reflecting the postsynaptic localization of S1R; S1R is also present on MN soma in non-
synaptically associated particles (encircled), which presumably correspond to ER stacks. c) A 
MN soma showing the association between NRG1 patches (green) with VAChT-labeled synaptic 
terminals (red); in the enlarged insets the displacement of the presynaptic VAChT-signal with 
respect to the postsynaptic NRG1 labeling can be observed. d) A MN soma showing that 
clusters of NRG1 (green) co-localize with Kv2.1 potassium channels (red) at C-bouton sites; in 
the enlarged insets the co-localizing signal is seen in yellow. e) A MN somata showing the co-
localization between p-ErbB2 (green) and most of the VAChT-labeled synaptic terminals (red); 
the enlarged insets show a detail of two VAChT-positive terminals (red), one of them 
colocalizing with p-ErbB2 immunolabeling (yellow). Scale bars: 10 μm in e (valid for a-d). 
 
Figure 2. Ultrastructure of C-bouton synaptic terminals. a) A presynaptic terminal (colored 
green) apposed to the surface of a MN cell body (colored red) displaying a SSC (delimited by 
arrows). b) A coated endocytic vesicle located at the periphery of the terminal in (a) (delimited 
by the dotted circle) is shown. c) A detail of a presumably endocytic/autophagic structure (*) 
within the nerve terminal is shown. d) A detail of compartmentation of pre- and postsynaptic 
elements in C-bouton is shown; the extracellular space (yellow) is interposed between the 
presynaptic terminal (green) and the postsynaptic MN cell body (red); the postsynaptic 
membrane displays an intimately associated SSC (blue) that exhibits continuity with ER 
membranes at the MN cell body (arrow). Scale bars: 250 nm. 
 
Figure 3. Disruption of NRG1 clusters at C-boutons in acutely stressed MNs. a-e) Lumbar spinal 
cord MNs were antidromically stimulated by electrical pulses delivered through sciatic nerve 
(5V, 10 Hz, 60 min). Double immunolabeling for NRG1 (green) and VAChT (blue) shows an 
important disruption of NRG1 clusters in stimulated MNs (c,d) versus those in the control side 
(a,b). Densitometric measurements of NRG1 labeling at VAChT-positive C-bouton sites shows 
the presence of a NRG1-depleted population of cholinergic synapses (e). f-k) MNs in lumbar 
spinal cords were subjected to orthodromic electrical field stimulation (5V, 10 Hz, 30 min). 
Double immunolabeling for NRG1 (green) and VAChT (blue) shows an important depletion of 
NRG1 in stimulated MNs (h,i) versus control ones (f,g). j) Ultrastructural morphology of C-
bouton area from a stimulated MN shows a disrupted SSC (arrows and colored blue in the 
inset), and the accumulation of large vesicles and vacuoles (red * in the inset), presumably 
representing disorganized ER at the cortical areas (delimited by double arrows) of the MN; 
presynaptic terminals are colored green, whereas postsynaptic MN is colored red; ER stacks in 
the deeper regions of MN soma appear not altered (yellow *). k) Densitometric analysis of 
VAChT and NRG1 in individual C-boutons demonstrates the huge depletion of NRG1 after 
stimulation. l-t) Effects of acute spinal cord slicing on C-bouton organization; MN cell bodies 
double immunolabeled for NRG1 (green) and VAChT (blue) in a spinal cord slice from a whole 
body PF-perfused mouse used as control (l,m) and in a sample obtained from an acute spinal 
cord oxygenated in artificial LCR and subsequently fixed by immersion in PF for 10 min (n,q). 
Note the dispersion and fragmentation of NRG1 clusters after slicing in conjunction with a 
depletion of VAChT-positive puncta (n,o) or the near complete depletion of NRG1 clusters 
(p,q). r,s) Semithin plastic sections of a control-fixed MN (r) and a MN fixed after 10 min of 
slicing (s) showing the cytoplasmic microvacuolization induced by the slicing process. t) The 
quantification of NRG1 cluster size (in µm2) shows its reduction after slicing, which is not 
prevented when a 0 Ca2+ medium is used. Values in graphs are shown as mean ± SEM; ***p < 
0.001 (Student’s t-test [e and k] and one way ANOVA, Bonferroni’s post-hoc test [t]); n in e = 
184, contralateral and 219, ipsilateral; n in k = 117, cont. and 53, stim., and n in t = 42-151.  
Scale bar: 500 nm in j (250 nm in inset); 20 μm in q (valid for a-d; f-I and l-p); 10 μm in s (valid 
for r). 
 
Figure 4. Correlative changes in MN cell bodies, glial cells and NRG1 clusters, and VAChT-
positive C-bouton synaptic sites after axotomy (either peripheral nerve irreversible transection 
or crush); only data from long-term (120-180 days) crush experiments allowing permissive 
reinnervation are shown. a) Measurements of MN soma size (*p < 0.05 and ***p < 0.001 vs. 0 
day, or crush vs. respective transection time point), one-way ANOVA, Bonferoni’s post-hoc 
test); n = 14-52 MNs from 2-4 animals. b) Time course of microglial and astroglial activation 
around axotomyzed MNs; *p < 0.05 and ***p < 0.001 vs. 0 day, or crush vs. respective 
transection time point (two-way ANOVA, Bonferroni’s post-hoc test); n = 5-25 sections from 2-
4 animals. c, d) Time course of density (c) and size (d) of VAChT- and NRG1-labeled C-boutons 
in axotomyzed MNs; *p < 0.05, **p < 0.01 and ***p < 0.001 vs. respective time-point of VAChT 
after axotomy, or crush vs. respective transection time point (two-way ANOVA, Bonferroni’s 
post-hoc test); n = in c = 10-52 and in d = 25-180 MNs, from 2-4 animals. e-h) Microglial 
reaction adjacent to MN cell bodies in the axotomized (ipsi) side (7 days after lesion) (f, g) 
compared to the unoperated (contra) side (e); MN cell bodies are delimited by Nissl staining 
(blue), C-bouton sites and microglia are visualized by NRG1 (green) and Iba1 (red) 
immunolabeling, respectively; note the prominent microglial recruitment seen around 
axotomyzed MN cell bodies (f, g). A detail of the spatial relation between microglial processes 
(Iba1, red) and clustered NRG1 (green) at C-bouton after a 3D reconstruction is shown in h. i) 
Number of NRG1-positive spots interacting with microglial processes; note their rapid 
reduction 24 h after axotomy, indicating that C-boutons are disrupted following the initial and 
rapid microglial recruitment; *p < 0.05 and ***p < 0.001 vs. 0 days (one-way ANOVA, 
Bonferroni’s post-hoc test); n = 10-21 3D reconstructed MNs. j-k) Interaction between 
microglial processes and C-bouton sites in 14 days-axotomyzed MNs; j) shows MN cell bodies 
(delimited by dashed lines) exhibiting microglial recruitment (Iba1, red) in relation with VAChT- 
(blue) and NRG1- (green) labeled puncta; note that the NRG1 spots, which are more intimately 
in contact with microglial processes, are devoid of VAChT immunolabeling (see the insets), 
suggesting that they correspond to denervated C-bouton sites; this aspect is quantified in k, 
showing the ratio between NRG1 and VAChT immunoreactivity in spots associated or not with 
Iba1 microglial profiles; note that postsynaptic NRG1 positive clusters still persisted in sites in 
which presynaptic VAChT is already removed by microglia. **p < 0.01 (Student’s t-test); n = 27 
clusters in the 2 3D reconstructed MNs showed in j. Data in graphs are shown as mean ± SEM. 
Scale bars: 50 μm in f (valid for e); 20 μm in g; 5 μm in h; 20 μm in j. 
 
Figure 5. Ultrastructural alterations of MN afferent synapses in concomitance with microglial 
recruitment at the surface of MN somata 7days after peripheral nerve transection. a-b) 
Semithin plastic sections of control (a) and axotomyzed (b) MN somata; note the recruitment 
of microglial cells (arrows), some of them, in close contact with the MN cell body surface of the 
injured MN. c-e) Electron micrographs of cell bodies and dendrites (colored red) of 
unaxotomized MNs showing abundant afferent synaptic boutons (colored violet and indicated 
with *); normal C-type synapses are shown in (d and e); observe that presynaptic terminals 
filled with synaptic vesicles are in front of the postsynaptic membrane which is in close 
association with SSC (arrows in d, and colored blue in d and e); the extracellular space, 
interposed between pre- and postsynaptic structures, was marked in yellow in d and e. f-I) 
Ultrastructural morphology of an axotomyzed MN cell body (colored red) in contact with 
recruited microglial cell (colored green); a degenerating dark terminal synaptic bouton is 
interposed between both cells (*); a portion of MN surface containing a presumably 
denervated SSC is seen contacting a microglial cell (delimited by a rectangle and enlarged in g). 
Another example of degenerating synaptic bouton (*), interposed between a recruited 
microglial cell (colored green) and an axotomyzed MN soma (dashed in red) is shown in (h). i-
k) A recruited microglial cell (colored green) over a denervated postsynaptic site of a C-
boutonon an axotomyzed MN (colored red) is shown in i; this postsynaptic locus  was formerly 
occupied by a presynaptic terminal which, once removed, its adjacent postsynaptic SSC 
structure remains as an indicator of the denervated C-bouton site; the relationship between 
these compartments are depicted in j and k as follows: MN soma red; microglia, green; SSC, 
blue; and extracellular space, yellow. Scale bars: 10 μm in b (valid for a), 500 nm in c and d, 
200 nm in e, 1 μm in f and h, 2.5 μm in I, and 200 nm in h. 
 
Figure 6. Animals were treated with vehicle or the ER-stress inhibitor salubrinal, subjected to 
sciatic nerve transection and examined 7 days later. a-f) The axotomyzed MN pool was 
analyzed by double immunofluorescent staining for BiP (green) and Iba1 (red). g-l) The same 
samples were labeled for Nissl (blue), NRG1 (green), VAChT (blue) and Iba1 (red). m-p) 
Quantitative analysis of changes in BiP-immunostaining intensity (m), microglial covering of 
MN soma perimeter (n) and density of VAChT- and NRG1-positive spots (per 100 µm2) (o and 
p, respectively); note that the treatment with salubrinal significantly reverts the BiP 
upregulation, microglial activation and C-bouton loss that occurs in/or adjacent to axotomyzed 
MNs; Data are shown as mean ± SEM. ***p < 0.001 vs. vehicle (Student’s t-test), n (vehicle and 
salubrinal, respectively) = 203 and 179 MNs (in m); 41 and 66 MNs (in n); 22 and 47 MNs (in o 
and p), from 3 animals. Scale bars: 40 µm in f (valid for a-e) and 10 µm in l (valid for g-k). 
 
Figure 7. Impact of the overexpression of different NRG1 isoforms in C-boutons on spinal cord 
MNs. a) Multiple fluorescent analysis of C-bouton-associated proteins in adult transgenic mice 
overexpressing HA-tag labeled NRG1 type III. The distribution of HA tag (red) NRG1 (visualized 
with an anti-pan-NRG1 antibody, green), and VAChT (blue) was detected in a Nissl-delimited 
MN cell body (gray); HA immunostaining exactly matches the anti-pan NRG1 signal and shows 
an extensive labeling along the whole MN surface; the VAChT-delimited C-bouton presynaptic 
sites display also association with NRG1, as detailed in the inset. b) The expression S1R, a 
protein focally concentrated in normal C-bouton SSCs, is largely expanded along the MN 
surface in NRG1 type III overexpressors: the extensive surface labeling of HA tag (red) and 
NRG1 (green) is associated with wide S1R immunostaining (blue). However, whereas there was 
an exact colocalization between HA and NRG1, sites containing S1R belong to separate 
microdomains, as evidenced after the plot profile analysis of fluorescence intensity depicted in 
c and d. e) The enlarged expression of NRG1 (green) at the MN surface is associated with the 
expansion of the SSC marker Kv2.1 (red); both signals are largely co-localized (yellow, in merge 
panel, and white, after co-localization analysis, Person´s R = 0.67). f) Show the altered 
distribution of M2 muscarinic AChRs in the NRG1 type III overexpressors. The extensive surface 
immunolabeling of M2 AChRs (green) exceeds the area corresponding to VAChT-labeled 
cholinergic terminals (red), as seen detailed in the inset. g) Multiple immunofluorescent 
analysis of C-boutons on a spinal cord MN from a transgenic mouse overexpressing HA-NRG1-
GIEF, a BACE1-cleaved variant of NRG1 type III [36]. The Nissl-delimitated MN cell body (gray) 
displays abundant HA-tag signal inside the MN cytoplasm and adjacent dendrites (red); HA-tag 
signal does not colocalize with either the NGR1, when detected with an anti-pan-NRG1 
antibody, (green), or VAChT-positive terminals (blue); however, C-bouton sites displaying 
VAChT puncta associated with postsynaptic NRG1, do not contain HA-positive signal, indicating 
the absence of BACE1-processed NRG1 type III (insets). The white granules in the merge image 
are lipofuscin particles emitting unspecific fluorescence visible in the three channels. h,i) 
Multiple fluorescent analysis of C-bouton-associated proteins in adult transgenic mice 
overexpressing NRG1 type I; h) A MN, visualized after Nissl staining (gray), the anti-pan-NRG1 
antibody (green) shows an extensive surface-associated immunolabeling; abundant C-bouton 
sites are visualized by S1R (red) and VAChT (blue) immunolabeling; NRG1 labeling at the MN 
surface exceeds out of the VAChT and S1R-containing synaptic sites (insets); i) A MN delimited 
by Nissl (gray) was immunolabeled for M2 AChR (green) and VAChT (red), showing the 
extensive surface expression of postsynaptic M2 AChR (inset). Both the number and size of C-
boutons were dramatically increased, in NRG1 type I overexpressors. Scale bars: 10 µm in i 
(valid for a-h). 
 
Figure 8. Quantification of C-bouton-associated markers in WT and transgenic mice 
overexpressing either NRG! type I or type III as indicated. The number and size of C-boutons in 
NRG1 type III overexpressors are not different from those in WT animals. However, in NRG1 
type I overexpressors, both the number and size of C-boutons are dramatically increased. The 
postsynaptic expression of M2 AChRs, S1R and Kv2.1 are also largely increased in type III NRG1 
overexpressors, whereas in NRG1 type I animals only M2 AChRs significantly increased. In all 
graphs values are shown as mean ± SEM; ***p < 0.001 (one-way ANOVA, Bonferroni’s post-
hoc test); n (WT, NRG1 type I and NRG1 type III , respectively) = 13, 13, and 9 MNs (in a); 92, 
88, and 44 MNs (in b); 11, 10, and 13 MNs (in c); 8, 17 and 10 (in d), 5, 10 and 7 MNs (in e) 
from 2-3 animals per condition. 
 
Figure 9. a-b) Electron micrographs of the cell body MN surface in transgenic mice 
overexpressing either NRG1 type III (a) or type I (b) isoforms. MN cytoplasm is dashed in red 
and C-bouton presynaptic terminals are marked in green. a) In NRG type III transgenic MNs, 
presynaptic terminals (*) are normal in size and located in face of enlarged and reduplicated 
SSC-like membranes (red arrows and bottom inset) in the postsynaptic MN; SSC-like 
membranes are extended far away from C-bouton sites. b) In NRG1 type I transgenic MNs the 
C-bouton presynaptic terminal (*) is highly enlarged and extends on the MN surface far away 
from the SSC-delimited area (colored blue) and detailed in the inset. c) The proposed changes 
in the structural and molecular organization of C-bouton synaptic sites, induced by 
overexpression of either NRG1 type III or type I isoforms, are depicted and compared to WT. 
Scale bar: 500 nm in b (valid for a). 
 
Target Source Host species Used 
concentration 
Grp78 (BiP) Stressgene (SPA-826), 
San Diego, CA, USA 






Goat polyclonal 1:250 





Chicken polyclonal 1:1000 
Her4/ErbB4 Cell Signalling (#4795) 
Danvers, MA, USA 
Rabbit monoclonal 1:50 
HA Tag Roche Diagnostics (11 
867 423 001), Sant 
Cugat del Vallès, 
Barcelona 
Rat monoclonal 1:500 
Ionised calcium-
binding adaptor 
molecule 1 (IBA1) 
Abcam (ab5076) Goat polyclonal 1:500 
Kv2.1 α-subunit NeuroMab (73-014), 
Davis, CA, USA 
Mouse monoclonal 1:100 
M2 muscarinic 
receptor 
Alomone Labs (AMR- 
002), Jerusalem, 
Israel  
Rabbit polyclonal 1:100 
Neu (C-18) (ErbB2) Santa Cruz 
Biotechnology 
(Sc-284), Dallas, TX, 
USA 





Mouse monoclonal 1:100 
NRG1 1α /β 1/2 Santa Cruz (sc-348) Rabbit polyclonal 1:300 




Rabbit polyclonal 1:250 
Neuregulin-CRD, Type 
III, clone N126B/31 





Rabbit polyclonal 1:100 
Sigma-1 receptor (S1R) Santa Cruz (sc-
137075) 
Mouse monoclonal 1:50 
SV2 Hybridoma bank 
(SV2), Iowa City, IA, 
USA 
Mouse monoclonal 1:1000 
Vesicular acetylcholine 
transporter (VAChT) 
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Supplementary Figure 1. a and b) Spinal cord MN somata showing NRG1 immunoreactivity 
obtained by the two indicated antibodies simultaneously used. Note that both antibodies 
detect clusters of NRG1 representing C-bouton synaptic sites. However, the rabbit pan-anti-
NRG1 antibody sc-348 displays more intense and clean immunolabeling than the mouse 
monoclonal MABN534, which is directed against type III NRG1-CRD. Scale bar: 10 µm in b 
(valid for a). 
e 
d 































Supplementary Figure 2. Clusters of NRG1 are present in association with MN synaptic 
afferents in distinct indicated animal species. As anti-VAChT antibodies were not reactive in 
species different from mammals, synaptic sites were labeled with anti-SV2 antibodies in 
xenopus (a), lizard (b) and chicken (c) samples; in pig samples (d) C-boutons were labeled with 
anti-VAChT antibodies, in human tissues (e-g), NRG1-positive spots were seen adjacent to MN 
surface, in an identical pattern as observed in mice. MN cell bodies were delimited with 
fluorescent Nissl staining (blue). Scale bars: 20 μm in d (valid for a-c), 100 μm in e, 20 μm in f 
and 10 μm in g. 
Nissl NRG1 CTB merge
Supplementary Figure 3. Spinal cord MN somata, retrograde labeled by intramuscular
injection of fluorescent CTB (red) was immunostained with anti-NRG1 antibody (green) and
counterstained with Nissl (blue). Note that the extensive incorporation of CTB in MN
cytoplasm does not overlap with NRG1 clustered at C-bouton sites. Scale bar: 20 μm.
3 1 
2 
Supplementary Figure 4. 3D volume rendering displaying the close relationship between 
microglial processes and C-bouton associated NRG1 clusters. Image was obtained from stacked 
0.5 μm optical confocal sections. A massive recruitment of microglia (red, 1) is seen around the 
MN soma (depicted, 3) 24 h after sciatic nerve axotomy. Microglial cells intimately interact with 
NRG1 clusters (green, 2). Scale bar: 5 μm. 
Supplementary Figure 5. Membrane disposition of NRG1 isoforms (adapted from [36,65]). 
Supplementary Figure 6. Impact of NRG1 overexpression in C-bouton organization of brainstem (non-
oculomotor [non-OCM, a, b and c] and oculomotor [OCM, d, e and f]) MNs. Selected sections were triple 
fluorescent labeled with NRG1 (green), VAChT (red) and MN cell bodies were delimited by either Nissl (a, and d) 
or NeuN (b, c, e and f) staining (blue). a) Non-OCM (ambiguous, cranial nerve [CN] X) MNs display NRG1 clusters 
associated with VAChT positive terminals, in an identical pattern to that observed in ventral horn spinal cord 
MNs. b and c) In samples from transgenic mice overexpressing either NRG1 type III or NRG1 type I, the observed 
changes are the same as those observed for ventral horn spinal cord MNs: the expanded superficial expression of 
postsynaptic NRG1 is detected in both models (green in b and c), whereas an important increase in the number 
of cholinergic VAChT positive terminals is noticed in NRG1 type I overexpressors (red in c). Identical results were 
observed in other brainstem non-OCM MN nuclei, such as: facial (CNVII), motor trigeminal (CNV) and hypoglosus 
(CNXII) (not shown). d) WT OCM (abducens, CNVI) MNs are devoid of VAChT positive C-bouton afferents, and 
clusters of NRG1 are scarce and not associated to cholinergic synapses. e) After overexpression of NRG1 type III, 
an increase in NRG1 clusters in OCM MN somata, which are non-associated to VAChT-positive terminals, are 
noticed. f) After NRG1 type I overexpression a dramatic increase in surface associated NRG1 in OCM MNs are 
detected, however, contrasting to that found in non-OCM MNs, excess of NRG1 is not able to induce cholinergic 
(VAChT-positive) synaptogenesis. Scale bars: 50 µm in a, d and f (valid for b, c and e), 10 µm in the inset in f (valid 
for all insets). 
